Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI)

Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

G. Chornokur, Hui-Yi Lin, J. Tyrer, et al.. (2015). PLoS ONE. Cited 841 times. https://doi.org/10.1371/journal.pone.0128106

GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

P. Pharoah, Ya‐Yu Tsai, S. Ramus, et al.. (2013). Nature genetics. Cited 378 times. https://doi.org/10.1038/ng.2564

Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study

Chenan Zhang, J. Doherty, S. Burgess, et al.. (2015). Human Molecular Genetics. Cited 138 times. https://doi.org/10.1093/hmg/ddv252

Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study.

Jue-Sheng Ong, Jue-Sheng Ong, G. Cuéllar-Partida, et al.. (2016). International journal of epidemiology. Cited 110 times. https://doi.org/10.1093/IJE/DYW207

A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer

E. Richards, Jennifer Permuth‐Wey, Yajuan Li, et al.. (2015). Oncotarget. Cited 103 times. https://doi.org/10.18632/oncotarget.5784

Genome-wide significant risk associations for mucinous ovarian carcinoma

L. Kelemen, K. Lawrenson, J. Tyrer, et al.. (2015). Nature genetics. Cited 84 times. https://doi.org/10.1038/ng.3336

Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer.

R. Hung, C. Ulrich, E. Goode, et al.. (2015). Journal of the National Cancer Institute. Cited 66 times. https://doi.org/10.1093/jnci/djv246

Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer

K. Lawrenson, Qiyuan Li, S. Kar, et al.. (2015). Nature Communications. Cited 61 times. https://doi.org/10.1038/ncomms9234

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

C. Phelan, K. Kuchenbaecker, J. Tyrer, et al.. (2017). Nature Genetics. Cited 49 times. https://doi.org/10.1038/ng.3826

Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10.

Bridget Charbonneau, M. Block, W. Bamlet, et al.. (2014). Cancer research. Cited 48 times. https://doi.org/10.1158/0008-5472.CAN-13-1051

Kernel canonical correlation analysis for assessing gene–gene interactions and application to ovarian cancer

N. Larson, G. Jenkins, M. Larson, et al.. (2013). European Journal of Human Genetics. Cited 38 times. https://doi.org/10.1038/ejhg.2013.69

Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk

S. Kar, J. Tyrer, Qiyuan Li, et al.. (2015). Cancer Epidemiology, Biomarkers & Prevention. Cited 37 times. https://doi.org/10.1158/1055-9965.EPI-14-1270

Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium

S. Johnatty, J. Tyrer, S. Kar, et al.. (2015). Clinical Cancer Research. Cited 34 times. https://doi.org/10.1158/1078-0432.CCR-15-0632

Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer.

K. Lawrenson, Edwin S. Iversen, J. Tyrer, et al.. (2015). Carcinogenesis. Cited 29 times. https://doi.org/10.1093/carcin/bgv138

Analysis of Over 10,000 Cases Finds No Association between Previously Reported Candidate Polymorphisms and Ovarian Cancer Outcome

Kristin L. White, R. Vierkant, Z. Fogarty, et al.. (2013). Cancer Epidemiology, Biomarkers & Prevention. Cited 25 times. https://doi.org/10.1158/1055-9965.EPI-13-0028

Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome

Bridget Charbonneau, K. Moysich, K. Kalli, et al.. (2014). Cancer Immunology Research. Cited 23 times. https://doi.org/10.1158/2326-6066.CIR-13-0136

Epithelial‐Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk

E. Amankwah, Hui-Yi Lin, J. Tyrer, et al.. (2015). Genetic Epidemiology. Cited 23 times. https://doi.org/10.1002/gepi.21921

Inherited Variants in Regulatory T Cell Genes and Outcome of Ovarian Cancer

E. Goode, M. DeRycke, K. Kalli, et al.. (2013). PLoS ONE. Cited 21 times. https://doi.org/10.1371/journal.pone.0053903

Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study.

Alice W. Lee, J. Tyrer, J. Doherty, et al.. (2015). Gynecologic oncology. Cited 21 times. https://doi.org/10.1016/j.ygyno.2014.12.017

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

A. Hollestelle, Frederieke H van der Baan, A. Berchuck, et al.. (2016). Gynecologic oncology. Cited 20 times. https://doi.org/10.1016/j.ygyno.2015.04.034

Germline Copy Number Variation and Ovarian Cancer Survival

B. Fridley, P. Chalise, Ya‐Yu Tsai, et al.. (2012). Frontiers in Genetics. Cited 14 times. https://doi.org/10.3389/fgene.2012.00142

Variation in NF-κB Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer

M. Block, Bridget Charbonneau, R. Vierkant, et al.. (2014). Cancer Epidemiology, Biomarkers & Prevention. Cited 11 times. https://doi.org/10.1158/1055-9965.EPI-13-0962

Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer

S. Winham, A. Pirie, Y. Chen, et al.. (2016). Cancer Epidemiology, Biomarkers & Prevention. Cited 10 times. https://doi.org/10.1158/1055-9965.EPI-15-0240